Regulation of gene expression by alternative polyadenylation
- Institution
- Wistar Institute, PA
- Principal investigator
- Bin Tian
- Funding
- $665K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Most mammalian genes harbor multiple cleavage and polyadenylation sites, or PASs, across the gene body, resulting in mRNA isoforms with different coding sequences (CDS) and/or 3’ untranslated regions (3’UTRs). Alternative cleavage and polyadenylation (APA) is an important layer of gene regulation, affecting gene expression levels, protein diversity, and mRNA metabolism. The APA isoform expression varies across cell types and is dynamically regulated in a growing number of cell conditions, such as cell proliferation and differentiation, change of metabolic states, and cellular stress. Our lab employs interdisciplinary approaches to study APA, involving molecular biology, functional genomics, and computational biology. Our long-term goal is to understand the functional genomics of APA across species as well as molecular mechanisms and cellular consequences of gene regulation by APA in different cell contexts and pathological conditions. In the next five years, we plan to address a few key gaps in the field: First, we plan to examine regulatory rules governing intronic polyadenylation that leads to early termination of transcription. Second, we will examine the role of 3’UTR isoform regulation in cell metabolic reprogramming, such as growth and autophagy. Third, we will investigate the mechanisms and consequences of the unique APA isoform profile in secretory cells.
LOADING MOONBASE SCORE
Questions for Wistar Institute
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NSF · Wistar InstituteNot yet scored
REU Site: Molecular Basis of Cellular Phenotypes (MBCP)
David Zuzga · $465K · 2026–2029
- NIH · Wistar InstituteNot yet scored
Individualized HIV Curative Combination Strategy against Persistent HIV on ART
Luis J Montaner · $3.6M · 2025–2030
- NIH · Wistar InstituteNot yet scored
MEPCS (Multi-epitope protease cleavage sites) vaccine for protecting against SIV rectal transmission
Qingsheng Li · $658K · 2025–2029